Please assess the completion status of the following clinical trial:

Trial Title: NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or non-pregnant, non-lactating female patients between the ages of 18 and 75 years~* Patients must have moderate to severe erosive esophagitis~Exclusion Criteria:~* Significant gastrointestinal bleeding~* Severe heart, lung, liver or kidney disease~* Esophagitis not related to acid reflux

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).